Characteristics of B cells from patients used in this study
| . | CLL . | Other B-cell lymphomas . | Healthy . | ||
|---|---|---|---|---|---|
| ZAP70−/mutated . | ZAP70+unmutated . | Total . | |||
| No. | 10 | 6 | 16 | 14 | 12 |
| Mean age, y | 63 | 53 | 58 | 72 | 57 |
| Male, % | 60 | 67 | 63 | 64 | 83 |
| Aiolos ratios, % | 89.8 ± 11.9 | 94.7 ± 10.9 | 91.6 ± 11.4 | 80.7 ± 17.1 | 85.8 ± 7.3 |
| Aio/Abl, transcript amounts | 3.86 ± 0.9 | 4.28 ± 0.6 | 4.02 ± 0.8 | 2.86 ± 1.2 | 2.78 ± 0.4 |
| . | CLL . | Other B-cell lymphomas . | Healthy . | ||
|---|---|---|---|---|---|
| ZAP70−/mutated . | ZAP70+unmutated . | Total . | |||
| No. | 10 | 6 | 16 | 14 | 12 |
| Mean age, y | 63 | 53 | 58 | 72 | 57 |
| Male, % | 60 | 67 | 63 | 64 | 83 |
| Aiolos ratios, % | 89.8 ± 11.9 | 94.7 ± 10.9 | 91.6 ± 11.4 | 80.7 ± 17.1 | 85.8 ± 7.3 |
| Aio/Abl, transcript amounts | 3.86 ± 0.9 | 4.28 ± 0.6 | 4.02 ± 0.8 | 2.86 ± 1.2 | 2.78 ± 0.4 |